![Peter McNamara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter McNamara
Keine laufenden Positionen mehr
Vermögen: 2 Mio $ am 30.06.2026
Profil
Dr. Peter McNamara is a Chief Scientific Officer at Tectonic Therapeutic, Inc. Dr. McNamara was previously employed as a Chief Scientific Officer by AVROBIO, Inc., an Executive Director-Biotherapeutics & Biotechnology by Novartis Institute for Functional Genomics, Inc., and a Director-Pharmacology by Phenomix Corp.
He received his undergraduate degree from National University of Ireland Galway and a doctorate degree from National University of Ireland Galway.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0.29% | 30.06.2026 | 55’285 ( 0.29% ) | 2 Mio $ | 30.06.2026 |
Aktive Positionen von Peter McNamara
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Peter McNamara
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Corporate Officer/Principal | 01.04.2021 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Corporate Officer/Principal | 01.08.2005 |
| TECTONIC THERAPEUTIC, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Peter McNamara
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
National University of Ireland Galway
 National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
